Opiant Pharmaceuticals (OPNT) Financials

$20.65

$0.00 (0.00%)

As on 02-Mar-2023 09:30EDT

Market cap

$109 Mln

Revenue (TTM)

$18 Mln

P/E Ratio

--

P/B Ratio

5.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Operating Revenue	17.73	40.73	27.40	38.24	13.51	13.98
Cost of Revenue	3.86	9.07	6.20	7.72	1.49	1.49
Gross Profit	13.69	31.66	21.21	30.52	12.02	12.49
Operating Expenses	45.37	26.50	23.45	19.60	33.21	33.68
Operating Profit (EBIT)	-31.51	5.16	-2.24	10.91	-21.19	-21.19
Other Income	--	--	--	--	--	--
Profit before Tax	-33.02	3.03	-2.29	11.42	-21.14	-21.14
Provision for Tax	0.10	0.02	-0.43	-0.18	0.05	0.05
Profit after Tax (Net Income)	-33.09	3.01	-1.86	11.59	-21.20	-21.20
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-33.84	--	3.01	-1.86	11.59	-21.20

Liabilities ($ Mln)	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Shareholder's Funds	20.50	46.84	35.49	34.42	16.86	16.86
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	14.41	16.74	18.70	0.25	2.70	2.70
Current Liabilities	7.04	6.85	6.42	5.61	9.83	9.83
Total Liabilities	48.99	70.43	60.61	40.28	29.39	29.39

Assets ($ Mln)	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Non-Current Assets	3.40	1.27	1.51	1.03	0.02	0.02
Current Assets	38.55	69.16	59.10	39.25	29.37	29.37
Total Assets	80.50	70.43	60.61	40.28	29.39	29.39
Total Debt*	16.51	17.08	18.98	0.77	0.77	--
Net Current Assets	--	--	62.31	52.68	33.64	19.54

Cashflow ($ Mln)	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Cash From Operating Activities	--	1.93	-2.03	4.06	-0.52	-0.52
Cash Flow from Investing Activities	--	--	-15.01	-0.05	-0.30	-0.30
Cash from Financing Activities	--	2.72	19.37	2.61	17.02	17.02
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
ROCE (%)	--	5.08	-4.15	43.90	-122.91	-200.02
ROE (%)	-110.73	7.31	-5.33	45.22	-125.72	-200.02
ROA (%)	-42.68	4.59	-3.69	33.28	-72.13	-105.46
EBIT Margin (%)	-176.58	12.68	-7.87	29.86	-156.47	-151.22
Net Margin (%)	-186.63	7.39	-6.79	30.32	-156.85	-151.59
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Revenue Growth (%)	-50.80	0.49	-0.28	1.83	-0.03	-0.24
EBIT Growth (%)	-1,193.34	339.41	-118.89	153.99	--	-396.35
Net Profit Growth (%)	-2,206.37	261.64	-116.06	154.70	--	-422.09
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	5.09	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.79	-6.15	28.61	-2.59	1.13	1.16
Close Price ($)	9.53	10.27	16.12	9.18	12.09	14.31
High Price ($)	37.71	37.71	19.90	18.23	29.55	51.90
Low Price ($)	7.34	7.34	6.79	8.05	9.98	11.51
Market Cap ($ Cr)	108.80	--	--	--	--	--

Solvency Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Debt to Equity	--	0.36	0.53	0.02	0.05	--
Short term debt to equity ratio	0.10	0.01	0.01	0.02	--	--
Current Ratio	5.48	10.10	9.21	7.00	2.99	2.99
Quick Ratio	5.48	--	--	--	--	--
Interest Coverage	-18.25	2.42	-16.46	26.08	-146.13	--

Operating Efficiency Ratios	TTM	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16	Jul-15	Jul-14	Jul-13
Debtors to sales (%)	0.23	32.73	32.52	18.88	33.22	32.11
Asset Turnover	0.23	0.62	0.54	1.10	0.46	0.70
Receivable days	--	99.72	107.50	55.92	121.35	107.62
Inventory Days	--	--	--	--	--	--
Payable days	--	127.63	126.23	57.95	277.52	409.68
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.